Literature DB >> 16555126

Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer.

Rakesh Kumar1, Anil Chauhan, Hongming Zhuang, Prem Chandra, Mitchell Schnall, Abass Alavi.   

Abstract

UNLABELLED: The present study was aimed to determine the clinicopathologic factors that predict false negative (FN) PET results in these patients.
METHODS: A total of 116 breast lesions in 111 patients (pre-menopausal 45; perimenopausal 15; post-menopausal 51) with known or suspicious of breast cancer who underwent FDG-PET scans for staging, were included in this study. The median age was 52+/-11 years (range 32-79 years). All PET studies results were correlated with follow-up surgical pathology results. A cut off value of 2.5 was considered for positive or negative PET results. Univariate and multivariate analyses were performed to identify factors associated with FN results.
RESULTS: Of 116 breast lesions, 85 were malignant and 31 were benign on histopathology. Of the 85 malignant lesions, 41 were true positive (TP) and 44 were FN. Among the 31 benign lesions, 30 were true negative and one was false positive. There was significant difference in the tumor size (p=0.003) and tumor grade (p=0.001) in patients with TP and FN PET results. Multivariate logistic regression demonstrated that tumor size (< or =10 mm) and low tumor grade were independently associated with FN results. No significant relationship of FN PET results was found with age, menopausal status, tumor type, c-erbB-2, estrogen and progesterone receptors, sentinel lymph node or distant metastasis, parenchymal density and multifocality of primary breast tumor.
CONCLUSION: In present study, tumor size and tumor grade are independent factors that predict FDG-PET results. Smaller tumors (< or =10 mm) and low-grade tumors are strong predictor of FN FDG-PET results.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16555126     DOI: 10.1007/s10549-006-9159-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  38 in total

Review 1.  Present and future role of FDG-PET/CT imaging in the management of breast cancer.

Authors:  Kazuhiro Kitajima; Yasuo Miyoshi
Journal:  Jpn J Radiol       Date:  2016-01-05       Impact factor: 2.374

Review 2.  Hybrid PET-dynamic CECT in the management of breast cancer.

Authors:  Rakesh Kumar; Chandan Jyoti Das
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

3.  A preliminary study to propose a diagnostic algorithm for PET/CT-detected incidental breast lesions: application of BI-RADS lexicon for US in combination with SUVmax.

Authors:  Mehrdad Bakhshayeshkaram; Yalda Salehi; Mehrshad Abbasi; Razieh Hashemi Beni; Sharareh Seifi; Maryam Hassanzad; Hamid Reza Jamaati; Farahnaz Aghahosseini
Journal:  Eur Radiol       Date:  2019-03-18       Impact factor: 5.315

4.  Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.

Authors:  David Groheux; Sylvie Giacchetti; Jean-Luc Moretti; Raphael Porcher; Marc Espié; Jacqueline Lehmann-Che; Anne de Roquancourt; Anne-Sophie Hamy; Caroline Cuvier; Laetitia Vercellino; Elif Hindié
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-06       Impact factor: 9.236

Review 5.  Prevalence and clinical significance of incidental F18-FDG breast uptake: a systematic review and meta-analysis.

Authors:  Francesco Bertagna; Giorgio Treglia; Emanuela Orlando; Lodovica Dognini; Luca Giovanella; Ramin Sadeghi; Raffaele Giubbini
Journal:  Jpn J Radiol       Date:  2013-12-13       Impact factor: 2.374

6.  18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes.

Authors:  Hye Ryoung Koo; Jeong Seon Park; Keon Wook Kang; Nariya Cho; Jung Min Chang; Min Sun Bae; Won Hwa Kim; Su Hyun Lee; Mi Young Kim; Jin You Kim; Mirinae Seo; Woo Kyung Moon
Journal:  Eur Radiol       Date:  2013-10-05       Impact factor: 5.315

Review 7.  18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization.

Authors:  Hossein Jadvar; Abass Alavi; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

8.  Regulation of the Warburg effect in early-passage breast cancer cells.

Authors:  Ian F Robey; Renu M Stephen; Kathy S Brown; Brenda K Baggett; Robert A Gatenby; Robert J Gillies
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

Review 9.  A systematic review of FDG-PET in breast cancer.

Authors:  S Escalona; J A Blasco; M M Reza; E Andradas; N Gómez
Journal:  Med Oncol       Date:  2009-03-11       Impact factor: 3.064

10.  Initial characterization of a dedicated breast PET/CT scanner during human imaging.

Authors:  Spencer L Bowen; Yibao Wu; Abhijit J Chaudhari; Lin Fu; Nathan J Packard; George W Burkett; Kai Yang; Karen K Lindfors; David K Shelton; Rosalie Hagge; Alexander D Borowsky; Steve R Martinez; Jinyi Qi; John M Boone; Simon R Cherry; Ramsey D Badawi
Journal:  J Nucl Med       Date:  2009-08-18       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.